<DOC>
	<DOC>NCT00916474</DOC>
	<brief_summary>Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.</brief_summary>
	<brief_title>Virology Follow up Study in Subjects Previously Treated With Telaprevir</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Received at least 1 dose of telaprevirbased treatment in 1 of the following clinical studies: VX05950104, VX05950104EU, VX06950106, VX06950107, VX07950108, VX08950111, or VX950TiDP24C216 Have baseline HCV viral sequencing data available from previous telaprevir study May not be currently participating in the antiviral followup period of an ongoing telaprevir trial. (Note: Subjects who have completed the required antiviral followup period but are still participating in the collection of patientreported outcomes data for their previous telaprevir study may be eligible.) For subjects participating in ongoing studies at the time of enrollment, have more than 90 elapsed days between the database lock or unblinding in the previous telaprevir study and Day 1 in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>